Modern day scientists are collecting overwhelming volumes of data – genomic data, phenotypic data, microbiome, exomes, clinical data, population health data and more. The rich and complex data sets now available to health, academic and life science professionals offer tremendous opportunity for future healthcare and drug discovery. The sheer volume coupled with the Tech Revolution is driving change to bioinformatics infrastructure, data visualisation and data analysis.
To ensure the Exchange offers the highest degree of relevancy for attendees, only senior R&D, R&D IT and QA/QC executives responsible for the design, development and delivery of laboratory informatics and digital transformation of the lab are invited. This exclusive format allows you to connect with those peers whose insights you respect most – through exceptional networking, business meetings with potential partners, contractors and suppliers and strategic information sharing sessions.
Sample management has become increasingly important in every phase of chemical and biological discovery. Control over factors like sample quality, process efficiency, metadata and miniaturization must be achieved to accelerate both academic and industrial programs. Further complexity arises in maintaining these factors when collaborating with an external research partner.
Carrying on with the momentum from our first Europe Conference in 2018, this event will bring together more than 1,000 scientists and technologists from around the world. Our theme for the 2019 Europe Conference is Innovative Technologies for Tomorrow’s Discoveries, we expect this programme to be filled with information that is most relevant to our community. As always, SLAS meetings are also a great opportunity to find out about the latest developments in Instrumentation, Assays, and Diagnostics.
The 2019 HIMSS Global Conference & Exhibition, February 11–15, 2019 in Orlando, is a health information and technology conference, bringing together 45,000+ professionals from 90+ countries for the education, innovation and collaboration they need to transform health through information and technology. Attendees can choose from 300+ education sessions, 1,300+ vendors, hundreds of special programs and endless networking events.
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
